ICUI as reported
ICU Medical, Inc. reported $2.16B of revenue over the trailing twelve months, −11% on the year before. 11 reported series are charted on this page, each one as filed.
$2.16B
Revenue, trailing twelve months · to Q1 2026 · −11% against the twelve months before
- Free Cash Flow
- $83M
Free Cash Flow · −37% year on year · trailing twelve months to Q1 2026
- Op Margin
- 2.0%
Op Margin · trailing twelve months to Q1 2026
- EPS
- $1.86
EPS · −148% year on year · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $2.16B | −11% | Q1 2026 |
| Net Income | $109M | n/a | Q3 2021 · 18 quarters behind |
| EPS | $1.86 | −148% | Q1 2026 |
| Gross Margin | 38% | n/a | Q1 2026 |
| Op Margin | 2.0% | n/a | Q1 2026 |
| Net Margin | 8.4% | n/a | Q3 2021 · 18 quarters behind |
| ROE | 6.4% | n/a | Q3 2021 · 18 quarters behind |
| ROA | 5.5% | n/a | Q3 2021 · 18 quarters behind |
| ROIC | 1.5% | n/a | Q1 2026 |
| Free Cash Flow | $83M | −37% | Q1 2026 |
| P/E | 96.5 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
ICU Medical, Inc. (ICUI) - Revenue & ProfitRevenue & ProfitICU Medical, Inc. (ICUI)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #23 of 27 by Smart Score